Imaging correlates of axonal swelling in chronic multiple sclerosis brains
- 11 April 2007
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 62 (3), 219-228
- https://doi.org/10.1002/ana.21113
Abstract
Objective T2-weighted magnetic resonance imaging is a sensitive tool for monitoring progression of multiple sclerosis, but it does not provide information on the severity of the underlying tissue damage. Measurement of T1 hypointensities and magnetization transfer ratio (MTR) can potentially distinguish lesions with more severe tissue damage. The objective of this study was to use image-guided pathology to determine histological differences between lesions that are abnormal only on T2-weighted images versus lesions that are abnormal on T2-weighted, T1-weighted, and MTR images. Methods A total of 110 regions were selected from postmortem magnetic resonance images of 10 multiple sclerosis patients. Regions were classified into three magnetic resonance imaging–defined categories: normal-appearing white matter; abnormal on T2-weighted image only (T2-only); and abnormal on T2-weighted, T1-weighted, and MTR images (T2T1MTR). Myelin status, lesion activity, astrocytosis, serum protein distribution, axonal area, and axonal loss were evaluated histopathologically. Results Comparisons between groups showed that T2T1MTR regions were more likely to be demyelinated (83% compared with 55% of T2-only regions) and more likely to be chronic inactive lesions (68% compared with 0% of demyelinated T2-only regions). There was no difference between T2-only and T2T1MTR regions in axonal area, but there was a significant difference in axonal count, indicating that axons in the T2T1MTR regions were enlarged relative to those in T2-only regions. Interpretation Axonal swelling and axonal loss were major pathological features that distinguish T2T1MTR regions from T2-only regions. Ann Neurol 2007Keywords
This publication has 41 references indexed in Scilit:
- Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: Have we been overly harsh in our assessment?Annals of Neurology, 2006
- Stereotactic co‐registration of magnetic resonance imaging and histopathology in post‐mortem multiple sclerosis brainNeuropathology and Applied Neurobiology, 2003
- The role of MRI as a surrogate outcome measure in multiple sclerosisMultiple Sclerosis Journal, 2002
- Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: Consensus report of the White Matter Study GroupJournal of Magnetic Resonance Imaging, 2002
- Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosisMultiple Sclerosis Journal, 2001
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Correlation between brain MRI lesion volume and disability in patients with multiple sclerosisActa Neurologica Scandinavica, 1996
- Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesionsJournal of Neuroimmunology, 1994
- A method for registration of 3-D shapesIEEE Transactions on Pattern Analysis and Machine Intelligence, 1992
- CORRELATION BETWEEN NMR SCAN AND BRAIN SLICE DATA IN MULTIPLE SCLEROSISThe Lancet, 1984